Navigation Links
Malignant tumor or benign cyst?
Date:3/10/2008

The results of a study presented today at the Society of Gynecologic Oncologys 39th Annual Meeting on Womens Cancer offer a promising development on the path toward better management of ovarian cancer. Researchers say testing women suspected of having ovarian cancer for a combination of proteins, or biomarkers in the blood called HE4 and CA 125, could be the key to predicting a womans risk for the disease dubbed the silent killer. Currently there is no adequate diagnostic test for ovarian cancer.

Roughly 20 percent of women will be diagnosed with an ovarian cyst or tumor at some point in their life, and only a small percentage of these women will be diagnosed with ovarian cancer, said Lead Researcher Richard Moore, M.D., assistant professor at The Warren Alpert Medical School of Brown University and a gynecologic oncologist in the Program in Womens Oncology at Women & Infants Hospital of Rhode Island. The problem is that current methods for distinguishing benign ovarian tumors from malignant ones are limited and as a result, women must undergo surgery without an accurate assessment as to their risk for having ovarian cancer prior to their surgery.

Dr. Moore notes that fewer than half of all ovarian cancer patients have their initial surgery performed by a gynecologic oncologist or surgeon with specialized training in the management of ovarian cancer. Our research is aimed at identifying patients at high risk for harboring an ovarian cancer so that they receive the right care from the right physician.

Currently, CA 125 is the only blood test that can be used to help predict a womans risk for ovarian cancer and to help with the clinical management of the disease. However, CA 125 alone lacks the sensitivity required for the detection of ovarian cancer prompting researchers to look at the ability of combinations of biomarkers to predict the presence of ovarian cancer. Earlier this year, Dr. Moore published results of a pilot study in t
'/>"/>

Contact: Stephanie Euler
stephanie@sternassociates.com
908-276-4344 x213
Fujirebio Diagnostics
Source:Eurekalert

1

GOOD

Page: 1 2 3

Related medicine news :

1. Early Results of Phase 2 Trial of Perifosine (KRX-0401) for the Treatment of Recurrent Malignant Gliomas Presented at the 12th Annual Scientific Meeting of Society for Neuro-Oncology
2. iNOS expression may links chronic biliary inflammation to malignant transformation
3. Protein in embryonic stem cells control malignant tumor cells
4. Protein in Human Embryonic Stem Cells Controls Malignant Tumor Cells
5. Tumors use enzyme to recruit regulatory T-cells and suppress immune response
6. Experimental anti-cancer drug made from corn lillies kills brain tumor stem cells
7. Study details regulation of vital tumor suppressor gene p53
8. Human C-reactive protein regulates myeloma tumor cell growth and survival
9. Customized virus kills brain tumor stem cells that drive lethal cancer
10. Study suggests brain tumors need treatment with multiple targeted drugs
11. Bright tumors, dim prospects

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...ich., Dec. 1 First Merc...Mercury" or the "Company") announced today that on... a quarterly cash dividend of $0.025 per share, to...rd at the close of business on December 15, 2009. ... ,, First Mercury Financial Corporation provid...
(Date:12/1/2009)...tral and South America, study finds , , ...nt of intensive care unit patients worldwide suffe...n the hospital, a new study finds. , Researcher...2007) on 13,796 patients, aged 18 and older, in 1,...nt of patients were classified as infected and 71 ...
(Date:12/1/2009)... affirming, isolating behaviors jump from friend ... News) -- A new study suggests that lonely people ...feel lonely, too. , "Loneliness can spread from... of separation," said James H. Fowler, co-author o... Journal of Personality and Social Psychology , a...
(Date:12/1/2009)... 1, 2009) Wistar Institute researchers and collab...w York University have identified immune system ma... tumors in people at high risk for developing lung... in Cancer Research , a journal of the American A...mple blood test to detect lung cancer in its earli...
(Date:12/1/2009)... Practitioners of any medical, legal or business r... a sigh of relief this week with the release of ,D... released over the holiday weekend, allows anyone ...s to do so quickly and seamlessly using just the i...) December 1, 2009 -- The iPhone App, released by ...
Breaking Medicine News(10 mins):Health News:Half of ICU Patients Suffer From Infections 2Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:Medical and Legal Professionals Find Relief Leveraging Apple iPhone App for Dictation and Transcription 'On the Go' 2
...for Industry Ashwini Kumar speaking at a national ...lised', // today urged the corporate sector in Ind...ob opportunities to disabled people. It is only th...s unflinching but industry experts should draw up ...
...s Prozac, Paxil and Zoloft, prescribed to the elde...ughts in its recipients//, especially in the first...edication to treat depression. Earlier studie... or SSRIs. But there has not been much research on...
...o do with seasons? An exhaustive study on suicide ...onounced with those born in spring or summer//. ...t occurred between 1979 and 2001 in England and Wa.... This tendency was more pronounced amongst women,...
...ion breast cancer survivors have been found to be ...dvances have helped in the longer management of t... that about a third of these long-term survivors d...les found that not all survivors suffer from fatig...
...ncluded that several young men treat their erectio...ithout a doctors prescription. // These results we...ged 18-25 at three Chicago universities. The r...iatric Academic Societies’ annual meeting. It reve...
...nducted on more than 57,000 children found that gr.../ like being poor or having a single mother who is...of becoming sick, immaterial of race or health ins...en, but this study is the first to show that incre...
Other Medicine News:Health News:Minister Of State For Industry Urges Corporate Sectors To Help India's Disabled Population 2Health News:Breast Cancer Survivors Growing in Numbers 2Health News:Young Men Treating Erection Problems without Doctors Prescription 2Health News:A New Study Shows Social Well Being Plays An Important Part In Childs Health 2Health News:A New Study Shows Social Well Being Plays An Important Part In Childs Health 3
(Date:12/1/2009)..., BOTHELL, Wash., Dec. 1 ...hat on November 20, 2009 it licensed to Chrono Nut...facture and sell four extended release dietary sup...delivery platform. In addition, SCOLR granted Chr...ducts in the United States on a nonexclusive basis...
(Date:12/1/2009)...LEN BURNIE, Md., Dec. 1 Sleep Solu...rvice provider for home testing and evaluation of ... named Richard Hassett, M.D., as its chief executi...f Matria Healthcare, during its growth from a $250...llion industry leader in total population health, ...
(Date:12/1/2009)... , TAI,AN, China, Dec. 1 /PRNewswire-Asia...Bulletin Board: CBPO) (Nasdaq: CBPO ) ("China Bio...ma-based biopharmaceutical companies in,China, tod...l to list its,common stock on the NASDAQ Global Ma... to begin trading on the NASDAQ on,Wednesday, Dece...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3China Biologic Products Approved to List on NASDAQ 2China Biologic Products Approved to List on NASDAQ 3US Oncology Inc Announces 24465 Million Senior Secured Notes Offering 47879 1US Oncology Inc Announces 24465 Million Senior Secured Notes Offering 47879 2DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 1DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 2DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 3DATATRAK Announces Receipt of NASDAQ Panel Decision to Delist Common Shares 47877 4Xceed Meets HTX CIHR Grant Milestone 3A Decreasing Sample Prep Time From Days to Less Than Eight Hours 12464 1Xceed Meets HTX CIHR Grant Milestone 3A Decreasing Sample Prep Time From Days to Less Than Eight Hours 12464 2
...ence Call to be Held at 9:00 a.m. Eastern Time Tod...United Therapeutics Corporation (Nasdaq: UTHR ) ...ug Administration (FDA) has approved ADCIRCA(TM) (... recommended dose of 40 mg, as the first once-dail...e treatment of pulmonary arterial hypertension (PA...
...LIS, Md., May 22 PharmAthene, Inc. (NYSE Amex: ...ountermeasures against biological and chemical thr...ed its comprehensive regulatory strategy to the U....e non-clinical and clinical development plans for ...inant protective antigen anthrax vaccine. , , The...
Other Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 2PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 3PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 4
... Web-based and RFID-enabled location system that a...ow and utilization of resources throughout the per...gileTrac collects patient information including lo... might experience. This information is directed to...
RoamAlert Eco
awarix Enterprise Visibility Solutions for Healthcare
Radianse Indoor Positioning Patient Location
Medicine Products: